These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 396053)

  • 1. Initial experiences with praziquantel in the treatment of human infections due to Schistosoma haematobium.
    Davis A; Biles JE; Ulrich AM
    Bull World Health Organ; 1979; 57(5):773-9. PubMed ID: 396053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary trials with praziquantel in human infections due to Schistosoma mansoni.
    Katz N; Rocha RS; Chaves A
    Bull World Health Organ; 1979; 57(5):781-5. PubMed ID: 396054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with praziquantel in the treatment of Nigerian patients infected with S. haematobium.
    Oyediran AB; Kofie BA; Bammeke AO; Bamgboye EA
    Arzneimittelforschung; 1981; 31(3a):581-4. PubMed ID: 7016124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentre trials of praziquantel in human schistosomiasis: design and techniques.
    Davis A; Wegner DH
    Bull World Health Organ; 1979; 57(5):767-71. PubMed ID: 317254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on praziquantel against Schistosoma haematobium.
    McMahon JE
    Arzneimittelforschung; 1981; 31(3a):579-80. PubMed ID: 7195249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with praziquantel of schoolchildren with concurrent Schistosoma mansoni and S. haematobium infections in Gezira, Sudan.
    Kardaman MW; Fenwick A; el Igail AB; el Tayeb M; Daffalla AA; Dixon HG
    J Trop Med Hyg; 1985 Apr; 88(2):105-9. PubMed ID: 3897559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind studies of tolerance to praziquantel in Japanese patients with Schistosoma japonicum infections.
    Ishizaki T; Kamo E; Boehme K
    Bull World Health Organ; 1979; 57(5):787-91. PubMed ID: 396055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary clinical trials with praziquantel in Schistosoma japonicum infections in the Philippines.
    Santos AT; Blas BL; Noseñas JS; Portillo GP; Ortega OM; Hayashi M; Boehme K
    Bull World Health Organ; 1979; 57(5):793-9. PubMed ID: 396056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Praziquantel in the treatment of mixed S. haematobium and S. mansoni infections.
    Omer AH
    Arzneimittelforschung; 1981; 31(3a):605-8. PubMed ID: 7195257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between Schistosoma haematobium and human immunodeficiency virus type 1: the effects of coinfection on treatment outcomes in rural Zambia.
    Mwanakasale V; Vounatsou P; Sukwa TY; Ziba M; Ernest A; Tanner M
    Am J Trop Med Hyg; 2003 Oct; 69(4):420-8. PubMed ID: 14640503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of oltipraz versus praziquantel for treatment of schistosomiasis with intestinal manifestation in the Gabon (Schistosoma intercalatum and S. haematobium).
    Kern P; Burchard GD; Dietrich M
    Tropenmed Parasitol; 1984 Jun; 35(2):95-9. PubMed ID: 6464192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of efficacy of praziquantel against Schistosoma mansoni infection.
    Massoud AA; el Kholy AM; Anwar WA
    J Trop Med Hyg; 1984 Jun; 87(3):119-21. PubMed ID: 6512904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative trial of oltipraz versus praziquantel in the treatment of urinary schistosomiasis in the Gabon.
    Burchard GD; Kern P; Baltes R; Dietrich M
    Tropenmed Parasitol; 1984 Jun; 35(2):91-4. PubMed ID: 6464191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
    Rugemalila JB; Asila J; Chimbe A
    J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance and efficacy of praziquantel in phase II A and II B therapeutic trials in Zambian patients.
    Davis A; Biles JE; Ulrich AM; Dixon H
    Arzneimittelforschung; 1981; 31(3a):568-74. PubMed ID: 7195247
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of urinary and intestinal bilharziosis with praziquantel. Apropos of 182 cases].
    Gentilini M; Brucker G; Danis M; Mogahed A; Datry A
    Bull Soc Pathol Exot Filiales; 1982 Nov; 75(5):523-9. PubMed ID: 7165900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trial of praziquantel in the treatment of urinary schistosomiasis in Senegal].
    Diallo S; Victorius A; Diouf F; Ndir O; Dieng Y; Bah IB
    Arzneimittelforschung; 1981; 31(3a):574-8. PubMed ID: 7195248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of praziquantel against the South African strains of Schistosoma haematobium and S. mansoni.
    Schutte CH; Osman Y; Van Deventer JM; Mosese G
    S Afr Med J; 1983 Jul; 64(1):7-10. PubMed ID: 6344270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of praziquantel on Schistosoma haematobium, S. japonicum and S. mansoni in primates.
    Webbe G; James C; Nelson GS; Sturrock RF
    Arzneimittelforschung; 1981; 31(3a):542-4. PubMed ID: 7195244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
    Keiser J; N'Guessan NA; Adoubryn KD; Silué KD; Vounatsou P; Hatz C; Utzinger J; N'Goran EK
    Clin Infect Dis; 2010 May; 50(9):1205-13. PubMed ID: 20350194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.